RS

Rini Sebastian

Active Director Director DIN 10246974
DIN 10246974 First appointment Jul 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Rini Sebastian

Data last updated:

Rini Sebastian is a Director at Trinitas Pharma Chem Private Limited (since 2023). The company operates in Paper.

DIN 10246974
Primary Designation Director
Industry Paper
First Appointment 20 Jul 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Trinitas Pharma Chem Private Limited U21002TZ2023PTC028955
Director20 Jul 20232023Active

Board colleagues of Rini Sebastian

NameDINCompanyDesignation
Jekab Subash Psebastean10246973Trinitas Pharma Chem Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Trinitas Pharma Chem Private Limited
Premium access

Shareholding and investment profile for Rini Sebastian

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rini Sebastian

Rini Sebastian currently holds 1 directorship: Trinitas Pharma Chem Private Limited (Director, since 20 Jul 2023).

Rini Sebastian was first appointed on 20 Jul 2023 as Director at Trinitas Pharma Chem Private Limited.

The current boards of Rini Sebastian's companies include Jekab Subash Psebastean (Trinitas Pharma Chem Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available